全文获取类型
收费全文 | 497342篇 |
免费 | 37746篇 |
国内免费 | 10888篇 |
专业分类
耳鼻咽喉 | 6684篇 |
儿科学 | 12476篇 |
妇产科学 | 8675篇 |
基础医学 | 40021篇 |
口腔科学 | 13256篇 |
临床医学 | 52269篇 |
内科学 | 57016篇 |
皮肤病学 | 6403篇 |
神经病学 | 27130篇 |
特种医学 | 12378篇 |
外国民族医学 | 40篇 |
外科学 | 52068篇 |
综合类 | 76303篇 |
现状与发展 | 19篇 |
一般理论 | 52篇 |
预防医学 | 58536篇 |
眼科学 | 6681篇 |
药学 | 46707篇 |
637篇 | |
中国医学 | 47593篇 |
肿瘤学 | 21032篇 |
出版年
2024年 | 1733篇 |
2023年 | 8661篇 |
2022年 | 15798篇 |
2021年 | 21079篇 |
2020年 | 20288篇 |
2019年 | 24560篇 |
2018年 | 22117篇 |
2017年 | 18981篇 |
2016年 | 16449篇 |
2015年 | 15521篇 |
2014年 | 31033篇 |
2013年 | 32673篇 |
2012年 | 28082篇 |
2011年 | 30286篇 |
2010年 | 24457篇 |
2009年 | 22045篇 |
2008年 | 21116篇 |
2007年 | 21541篇 |
2006年 | 18737篇 |
2005年 | 16126篇 |
2004年 | 13213篇 |
2003年 | 11576篇 |
2002年 | 9122篇 |
2001年 | 7967篇 |
2000年 | 6730篇 |
1999年 | 5722篇 |
1998年 | 4668篇 |
1997年 | 4370篇 |
1996年 | 3728篇 |
1995年 | 3560篇 |
1994年 | 3361篇 |
1993年 | 2776篇 |
1992年 | 2720篇 |
1991年 | 2386篇 |
1990年 | 2119篇 |
1989年 | 1939篇 |
1988年 | 1833篇 |
1987年 | 1598篇 |
1985年 | 4712篇 |
1984年 | 5754篇 |
1983年 | 4059篇 |
1982年 | 4758篇 |
1981年 | 4128篇 |
1980年 | 3665篇 |
1979年 | 3362篇 |
1978年 | 2886篇 |
1977年 | 2184篇 |
1976年 | 2488篇 |
1975年 | 1837篇 |
1974年 | 1609篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
腕管综合征主要症状体征敏感性与特异性的比较 总被引:5,自引:1,他引:4
目的 比较腕管综合征 (carpaltunnelsyndrome ,CTS)主要症状、体征的敏感性与特异性。方法 对 10 1例 ( 162只手 )进行症状严重程度与功能状况的询问 ,感觉、运动功能的检查 ;其中 62只手在术后 6周再次测定。结果 162只患手中 15 8只具有典型症状 ( 98% )。Phalen征、前臂正中神经加压征、Semmes Weinstein单丝纤维测试阳性率分别为 98%、96%、82 %。 87%的患手出现肌力下降 ,拇短展肌肌力测定 (定量法 )结果显示 ,与徒手法相比 ,不同性别间、术前与术后的差异均具非常显著意义 (P <0 .0 1)。结论 典型症状、Phalen征、前臂正中神经加压征、拇短展肌肌力变化的敏感性与特异性最高 ,拇短展肌肌力定量法测定是判断腕管综合征严重程度、评定疗效的一个良好的客观指标。 相似文献
992.
BACKGROUND: Patient education is integral part of any diabetes therapy in Germany, but elderly patients are not able to follow the variety of topics comprising standard treatment and teaching programmes (TTP), primarily due to impaired neuropsychological function. This leads to deficits in diabetes knowledge and hindered ability for diabetes self-management. AIM: To evaluate structured TTP for geriatric patients with impaired cognitive function. PATIENTS AND METHODS: A neuropsychological examination was performed on all patients over 54 years [n=102, age 68.6 +/- 8.7 years, diabetes duration 10.3 (0.03-35.4) years, HbA1c 10.3 +/- 1.7% (HPLC, Diamat, NR 4.5-6.3%), cognitive function 87.7 +/- 12.3 IQ points] who took part in TTP for insulin therapy. Patients with impaired cognitive function participated either in the standard TTP of Berger [n = 35, age 67.6 +/- 8.9 years, diabetes duration 9.9 (0.04-35.4) years, HbA1c 10.3 +/- 2.0%] or in the specialized structured geriatric DICOF-TTP [n=33, age 70.4 +/- 8.2 years, diabetes duration 10.4 (0.03-24.9) years, HbA1c 10.7 +/- 1.8%]. RESULTS: After TTP there were no differences in knowledge and ability for diabetes self-management (standard/DICOF: knowledge 11.0 +/- 2.6 vs. 12.2 +/- 2.7 points, P = 0.11; handling 14.9 +/- 3.3 vs. 15.9 +/- 2.5 points, P = 0.18). However, patients who took part in the DICOF programme showed better scores in satisfaction with the education programme [standard/DICOF 44.7 (31-57) vs. 52.5 (45-59) points, P < 0.001]. Six months later the DICOF participants showed better results regarding diabetes self-management (standard/DICOF: handling 12.5 +/- 4.1 vs. 15.9 +/- 3.1 points, P = 0.001). Both groups showed HbA1c decrease (8.3 +/- 1.4 vs. 8.5 +/- 1.3%, P=0.62) and similar incidence of acute complications. CONCLUSIONS: Elderly patients with impaired cognitive function should take part in specialized structured TTP. This leads to both better satisfaction with the education programme and an improved ability for diabetes self-management. 相似文献
993.
天然抗氧化剂多靶点作用在防治心脑血管疾病中的研究进展 总被引:8,自引:0,他引:8
从天然抗氧化剂的多靶点作用角度阐述其防治心脑血管疾病的效应机制、研究动态,并提出存在的问题及解决思路。 相似文献
994.
急性肠系膜静脉血栓形成16例临床分析 总被引:1,自引:0,他引:1
目的 分析急性肠系膜静脉血栓形成 (ASMVT)的临床特征和诊断方法。方法 对北京友谊医院 1985年 10月至 2 0 0 2年 10月确诊的 16例ASMVT的临床资料进行分析 ,并结合文献 ,总结ASMVT的临床特征和诊断方法。结果 16例ASMVT患者 ,年龄 19~ 6 4岁 (平均 4 5 9岁 )。主要症状有腹痛 ( 16 / 16 )、腹胀 ( 16 / 16 )、呕吐 ( 10 / 16 )、发热 ( 8/ 16 ) ,主要体征有腹部膨隆 ( 16 / 16 )、腹膜刺激征( 16 / 16 )。误诊率 75 % ( 12 / 16 ) ,死亡率 4 4 % ( 7/ 16 )。结论 ASMVT的临床表现有一定的特征 ,早期彩色超声检查、诊断性腹腔穿刺、结合CT或肠系膜上动脉造影异常发现可对ASMVT做出正确的诊断 ,早期手术可以降低死亡率 相似文献
995.
Polygenesregulateapoptosis .bcl 2isananti apoptosisgene ,whilebaxisapro apoptosisgene .L Tetrahydropalmatine (L THP) ,akindofalkaloidextractedfromtraditionalChinesemedicineRhizomacorydalis,possessesanalgesic ,sedativeandhypnoticeffects.Recently ,ithasbeen… 相似文献
996.
997.
998.
仲跻云 《山东医大基础医学院学报》2003,17(4):234-235
目的 :探讨改良泪道探通术注入素高捷疗眼膏治疗泪道阻塞的临床效果。方法 :用 7~ 9号腰脊穿刺针针头去尖 ,磨光后制成改良空管式泪道探针。为慢性泪囊炎 98例、10 2眼探通泪道后沿空管注入素高捷疗眼膏 ,使之布满泪道内壁 ,尽快修复探通的泪道内皮 ,达到扩张疏通的目的。以同一疾病 84例、85眼为对照组 ,以 1~ 3号银质泪道扩张针扩通泪道 ,留针 15min ,隔日 1次 ,共扩张 2~ 3次 ,扩张后用 0 .2 5 %氯氟液冲洗。结果 :术后随访 3个月 ,观察组治愈率为 97.0 5 %,对照组治愈率为 9.4 1%,差异有高度显著性 (P<0 .0 1)。 结论 :用改良的泪道探针探通泪道后注入素高捷疗眼膏 ,促使泪道修复 ,是治疗泪道阻塞或狭窄的有效方法。 相似文献
999.
Objective To identify the direct causes of drug relapse and abstainers’ demand, and to develop programs for the prevention of drug relapse. Methods Abstainers in a Compulsive Detoxification Center in Wuhan City, capital of Hubei Province were randomly selected. An investigation on the direct causes of drug relapse and abstainers’ demands was conducted with multiple-choice questionnaires and face to face interviews. Data were analyzed with SPSS 12.0. Results The direct causes leading to drug relapse included: temptation to use drug again by themselves or by their drug mates, seeking pleasure and ecstasy from drug use, relatively well off living, mental stress, irritation, demoralization, family conflicts, unemployment, feeling distrusted by the family, lack of care and love from the family, and discrimination by others. abstainers’ demands after detoxification and returning to the society included: care and support from the family, employment assistance, changing living environment, understanding by others, support from the society, and keeping far away from drugs. Conclusions Environmental factors are the direct causes of drug relapse, and negative irritation is its predisposing causes. Leaving former residence, more care and help given by both the family and the society and raising their overall quality of life are the demands of abstainers. 相似文献
1000.
Andrea von Berg Renate Engelstätter Predrag Minic Miodrag Sréckovic Maria Luz Garcia Garcia Tadeusz Lato Jan H. Vermeulen Stefan Leichtl Stefan Hellbardt Thomas D. Bethke 《Pediatric allergy and immunology》2007,18(5):391-400
Ciclesonide is an onsite-activated inhaled corticosteroid (ICS) for the treatment of asthma. This study compared the efficacy, safety and effect on quality of life (QOL) of ciclesonide 160 microg (ex-actuator; nominal dose 200 microg) vs. budesonide 400 microg (nominal dose) in children with asthma. Six hundred and twenty-one children (aged 6-11 yr) with asthma were randomized to receive ciclesonide 160 microg (ex-actuator) once daily (via hydrofluoroalkane metered-dose inhaler and AeroChamber Plus spacer) or budesonide 400 microg once daily (via Turbohaler) both given in the evening for 12 wk. The primary efficacy end-point was change in forced expiratory volume in 1 s (FEV1). Additional measurements included change in daily peak expiratory flow (PEF), change in asthma symptom score sum, change in use of rescue medication, paediatric and caregiver asthma QOL questionnaire [PAQLQ(S) and PACQLQ, respectively] scores, change in body height assessed by stadiometry, change in 24-h urinary cortisol adjusted for creatinine and adverse events. Both ciclesonide and budesonide increased FEV1, morning PEF and PAQLQ(S) and PACQLQ scores, and improved asthma symptom score sums and the need for rescue medication after 12 wk vs. baseline. The non-inferiority of ciclesonide vs. budesonide was demonstrated for the change in FEV1 (95% confidence interval: -75, 10 ml, p = 0.0009, one-sided non-inferiority, per-protocol). In addition, ciclesonide and budesonide showed similar efficacy in improving asthma symptoms, morning PEF, use of rescue medication and QOL. Ciclesonide was superior to budesonide with regard to increases in body height (p = 0.003, two-sided). The effect on the hypothalamic-pituitary-adrenal axis was significantly different in favor of ciclesonide treatment (p < 0.001, one-sided). Both ciclesonide and budesonide were well tolerated. Ciclesonide 160 microg once daily and budesonide 400 microg once daily were effective in children with asthma. In addition, in children treated with ciclesonide there was significantly less reduction in body height and suppression of 24-h urinary cortisol excretion compared with children treated with budesonide after 12 wk. 相似文献